High Growth Tech Stocks To Explore This November 2024

Date:

Amidst a backdrop of record highs in U.S. indexes and broad-based gains, smaller-cap indexes have notably outperformed large-caps, driven by positive sentiment from strong labor market indicators and housing sales reports. In this environment of optimism and potential interest rate cuts by the Federal Reserve, exploring high-growth tech stocks can be appealing as they often exhibit innovative potential and resilience that aligns well with the current market dynamics.

Name

Revenue Growth

Earnings Growth

Growth Rating

Waystream Holding

22.16%

113.25%

★★★★★★

Ascelia Pharma

76.15%

47.16%

★★★★★★

Sarepta Therapeutics

24.00%

42.49%

★★★★★★

Pharma Mar

25.97%

56.89%

★★★★★★

CD Projekt

21.17%

29.59%

★★★★★★

TG Therapeutics

34.66%

56.98%

★★★★★★

Elliptic Laboratories

65.73%

103.55%

★★★★★★

Alkami Technology

21.89%

98.60%

★★★★★★

Alnylam Pharmaceuticals

22.35%

70.33%

★★★★★★

Travere Therapeutics

31.70%

72.51%

★★★★★★

Click here to see the full list of 1283 stocks from our High Growth Tech and AI Stocks screener.

Here’s a peek at a few of the choices from the screener.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Beijing Vastdata Technology Co., Ltd. provides data technology services in China and has a market capitalization of CN¥4.78 billion.

Operations: Vastdata Technology focuses on software and information technology services, generating CN¥365.24 million in revenue from this segment.

Despite its current unprofitability, Beijing Vastdata Technology is on a trajectory that could see significant changes. With revenue growth forecasted at an impressive 41.8% annually, surpassing the Chinese market’s average of 13.8%, the company is positioning itself as a potentially strong player in tech. This growth comes alongside an anticipated earnings increase of 119.7% per year, signaling a robust upward trend once it achieves profitability in the next three years. Recent financials reveal reduced losses and increased sales, with revenues hitting CNY 266.87 million for the nine months ending September 2024—a substantial rise from CNY 163.46 million in the previous year period—highlighting effective strategies to reverse prior downturns despite ongoing challenges like shareholder dilution and share price volatility.

SHSE:603138 Earnings and Revenue Growth as at Nov 2024

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Beijing Zhong Ke San Huan High-Tech Co., Ltd. operates in the high-tech industry with a market cap of CN¥12.66 billion.

Share post:

Popular

More like this
Related

Liverpool fail to win in Fulham thriller but show key trait in title race

Two points dropped, one test of character passed. It...

Why can’t the Lakers score? Examining their sudden cold streak

Austin Reaves paused as he held a microphone in...

Nelly Korda, Akshay Bhatia using new drivers at Grant Thornton Invitational

Nelly Korda, the top-ranked female golfer in the world...